Open AccessOR16-2 Osilodrostat Treatment in Cushing's Disease (CD): Results from a Phase III, Multicenter, Double-Blind, Randomized Withdrawal Study (LINC 3)
Author(s) -
Beverly M. K. Biller,
John NewellPrice,
Maria Fleseriu,
Xavier Bertagna,
James W. Findling,
Akira Shimatsu,
Eun Jig Lee,
Feng Gu,
Richard J. Auchus,
Rattana Leelawattana,
André Lacroix,
Jung Hee Kim,
Audrey Laplanche,
P.R. O'Connell,
Libuse Tauchmanovà,
Alberto M Pedroncelli,
Rosario Pivonello
Publication year - 2019
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/js.2019-or16-2
Subject(s) - medicine , tolerability , randomized controlled trial , randomization , placebo , clinical endpoint , population , adverse effect , gastroenterology , alternative medicine , environmental health , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom